PLK1 depletion and plumbagin treatment resulted in identical phenotypes (i.e. G2/M arrest and apoptosis), which raises the possibility that plumbagin suppresses cell proliferation and survival by regulating PLK1 expression in ESCC cells. The gene discussed is PLK1; the disease is esophageal squamous cell carcinoma.